2seventy bio (TSVT) News Today $3.52 -0.40 (-10.20%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period US$8.25: That's What Analysts Think 2seventy bio, Inc. (NASDAQ:TSVT) Is Worth After Its Latest ResultsNovember 15 at 7:50 PM | finance.yahoo.com2seventy bio Reports Strong Growth in Abecma SalesNovember 15 at 12:17 AM | markets.businessinsider.comTD Cowen Reaffirms Their Hold Rating on 2seventy bio (TSVT)November 15 at 12:17 AM | markets.businessinsider.com2seventy Bio's Losses Narrow, Sales DipNovember 13, 2024 | fool.com2seventy bio Inc (TSVT) Q3 2024 Earnings Call Highlights: Strong Abecma Growth and Strategic ...November 13, 2024 | finance.yahoo.com2seventy bio, Inc. (TSVT) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.com2seventy bio Earnings PreviewNovember 12, 2024 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTNovember 10, 2024 | prnewswire.com2seventy bio (TSVT) to Release Quarterly Earnings on Tuesday2seventy bio (NASDAQ:TSVT) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Arvinas Holding Company (ARVN), 2seventy bio (TSVT)November 5, 2024 | markets.businessinsider.com2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor ConferenceNovember 4, 2024 | finance.yahoo.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTNovember 2, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTOctober 25, 2024 | prnewswire.comTD Cowen Sticks to Its Hold Rating for 2seventy bio (TSVT)October 22, 2024 | markets.businessinsider.com2seventy bio, Inc. (NASDAQ:TSVT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages2seventy bio, Inc. (NASDAQ:TSVT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, four have assigneOctober 21, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTOctober 17, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTOctober 9, 2024 | prnewswire.comTSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the FirmOctober 9, 2024 | globenewswire.comTSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the FirmOctober 7, 2024 | prnewswire.comHealthcare of Ontario Pension Plan Trust Fund Sells 268,100 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)Healthcare of Ontario Pension Plan Trust Fund cut its stake in 2seventy bio, Inc. (NASDAQ:TSVT - Free Report) by 15.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,468,500 shares of the company's stockOctober 6, 2024 | marketbeat.com2seventy bio, Inc. (NASDAQ:TSVT) Shares Bought by Marshall Wace LLPMarshall Wace LLP boosted its stake in shares of 2seventy bio, Inc. (NASDAQ:TSVT - Free Report) by 50.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 667,023 shares of the company's stock after purchasing an aOctober 4, 2024 | marketbeat.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTOctober 3, 2024 | prnewswire.comTSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the FirmSeptember 29, 2024 | prnewswire.com2seventy bio, Inc. (NASDAQ:TSVT) Sees Significant Decrease in Short Interest2seventy bio, Inc. (NASDAQ:TSVT - Get Free Report) was the recipient of a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 5,130,000 shares, a decline of 13.8% from the August 31st total of 5,950,000 shares. Approximately 10.6% of the shares of the company are sold short. Based on an average daily volume of 402,300 shares, the days-to-cover ratio is presently 12.8 days.September 28, 2024 | marketbeat.comBuy Rating Affirmed for 2seventy bio Despite Trial Setback: Niche Market Strategy and Safety Profile Underpin Positive OutlookSeptember 28, 2024 | markets.businessinsider.comTSVT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 2seventy bio, Inc. and Encourages Investors to Contact the FirmSeptember 27, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 2seventy bio, Inc. - TSVTSeptember 27, 2024 | prnewswire.comPetri Dish: 2seventy, BMS halt Phase 3 trial; Flagship spinout names CSOSeptember 26, 2024 | bizjournals.com2seventy bio, Inc. (NASDAQ:TSVT) Given Average Rating of "Moderate Buy" by Brokerages2seventy bio, Inc. (NASDAQ:TSVT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, four havSeptember 26, 2024 | marketbeat.com2seventy, Bristol Myers Discontinue Enrollment In Phase 3 KarMMa-9 Study - Quick FactsSeptember 25, 2024 | markets.businessinsider.comBristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To ProfitabilitySeptember 25, 2024 | finance.yahoo.com2seventy Bio stops enrolling patients in blood cancer therapy studySeptember 25, 2024 | reuters.com2seventy, Bristol Myers Drop Abecma Study in Newly Diagnosed PatientsSeptember 25, 2024 | marketwatch.com2seventy bio Provides Update on KarMMa-9 Study and Previews Anticipated Strong Third Quarter Revenue PerformanceSeptember 25, 2024 | finance.yahoo.com2seventy bio, Inc. (NASDAQ:TSVT) Shares Purchased by Venator Management LLCVenator Management LLC boosted its position in shares of 2seventy bio, Inc. (NASDAQ:TSVT - Free Report) by 49.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 485,000 shares of the company's stock after acquiSeptember 19, 2024 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Walgreens Boots Alliance (WBA), 2seventy bio (TSVT) and Repare Therapeutics (RPTX)August 30, 2024 | markets.businessinsider.com2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare ConferenceAugust 29, 2024 | finance.yahoo.comInsider Selling: 2seventy bio, Inc. (NASDAQ:TSVT) Insider Sells 7,816 Shares of StockAugust 19, 2024 | insidertrades.com2seventy bio, Inc. (NASDAQ:TSVT) Insider Jessica Snow Sells 7,816 Shares2seventy bio, Inc. (NASDAQ:TSVT - Get Free Report) insider Jessica Snow sold 7,816 shares of the firm's stock in a transaction that occurred on Wednesday, August 14th. The shares were sold at an average price of $4.32, for a total transaction of $33,765.12. Following the completion of the transaction, the insider now owns 156,330 shares in the company, valued at approximately $675,345.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.August 16, 2024 | marketbeat.comEarnings call: 2Seventy Bio sees progress with ABECMA in Q2 2024August 13, 2024 | uk.investing.com2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | insidermonkey.com2seventy bio, Inc. (TSVT) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comVanguard Group Inc. Has $19.96 Million Holdings in 2seventy bio, Inc. (NASDAQ:TSVT)Vanguard Group Inc. lessened its holdings in 2seventy bio, Inc. (NASDAQ:TSVT - Free Report) by 6.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,731,679 shares of the company's stock after selling 254,091 shareAugust 12, 2024 | marketbeat.comLeerink Partners Keeps Their Buy Rating on 2seventy bio (TSVT)August 10, 2024 | markets.businessinsider.com2seventy bio, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearAugust 10, 2024 | finance.yahoo.comHold Rating on 2seventy bio: Balancing Modest Sales Growth Against Competitive Market PressuresAugust 8, 2024 | markets.businessinsider.com2seventy bio, Inc. (NASDAQ:TSVT) Given Consensus Recommendation of "Moderate Buy" by Analysts2seventy bio, Inc. (NASDAQ:TSVT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the ten research firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendAugust 7, 2024 | marketbeat.com2seventy bio (TSVT) to Release Earnings on Wednesday2seventy bio (NASDAQ:TSVT) will be releasing earnings before the market opens on Wednesday, August 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=617700)August 6, 2024 | marketbeat.com379,586 Shares in 2seventy bio, Inc. (NASDAQ:TSVT) Bought by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. bought a new stake in shares of 2seventy bio, Inc. (NASDAQ:TSVT - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 379,586 shares of the company's stock, valued at approAugust 1, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: 2seventy bio (TSVT) and Abbott Laboratories (ABT)July 29, 2024 | markets.businessinsider.com Get 2seventy bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter. Email Address There is a little known company that is changing warfare (Ad)With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t TSVT Media Mentions By Week TSVT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSVT News Sentiment▼0.150.55▲Average Medical News Sentiment TSVT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSVT Articles This Week▼102▲TSVT Articles Average Week Get 2seventy bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TSVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cronos Group News Today Erasca News Today Tyra Biosciences News Today Pliant Therapeutics News Today Replimune Group News Today Dianthus Therapeutics News Today Relay Therapeutics News Today Evolus News Today Anavex Life Sciences News Today Immunome News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSVT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 2seventy bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 2seventy bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSVT Stock Alerts